Company intelligence / Profile preview

MedicaSafe

New York City, New York, United Statesmedicasafe.com ↗

Ownership: Private
Development stage: Commercial

Overview

MedicaSafe has developed a patented smart drug-device combination system that dispenses buprenorphine/naloxone for opioid use disorder. The system tracks patient adherence and provides real-time data to clinicians to improve compliance and enable earlier intervention. The company’s lead program has received NIH funding and aims to address the opioid epidemic by reducing misuse, diversion, and accidental consumption[1][2][3].

Clinical results have not been published; the company was seeking FDA clearance as of late 2019[4][5].

Therapeutic areas: OtherPsychiatry
Modalities: DeviceSmall molecule (buprenorphine/naloxone)Combination drug-device product
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

buprenorphine + naloxone

Commercial

Indications: Opioid use disorder

Partnerships

National Institutes of Health (NIH) – grant funding partner[2][3]

Beyond the preview

Go deeper on MedicaSafe.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MedicaSafe.

Explore the full profile